Gail Boudreaux - Mar 1, 2023 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
President and CEO, Director
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Stock symbol
ELV
Transactions as of
Mar 1, 2023
Transactions value $
-$9,416,064
Form type
4
Date filed
3/3/2023, 03:13 PM
Previous filing
Nov 4, 2022
Next filing
Mar 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Tax liability -$1.16M -2.47K -2.21% $469.03 109K Mar 1, 2023 Direct F1
transaction ELV Common Stock Award $0 +8.42K +7.71% $0.00 118K Mar 1, 2023 Direct F2
transaction ELV Common Stock Award $0 +35.9K +30.51% $0.00 153K Mar 1, 2023 Direct F3
transaction ELV Common Stock Tax liability -$8.26M -17.6K -11.48% $468.78 136K Mar 2, 2023 Direct F1, F4
holding ELV Common Stock 60 Mar 1, 2023 Shares Held in Spouse's Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELV Employee Stock Option (Right to Buy) Award $0 +32.4K $0.00 32.4K Mar 1, 2023 Common Stock 32.4K $469.03 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2 Represents restricted share units. Restrictions lapse as follows: 2,807 shares each on 3/1/2024 and 3/1/2025 and 2,808 shares on 3/1/2026.
F3 Represents performance based restricted share units. Restrictions lapse on 3/2/2023.
F4 Balance includes 236.42 shares acquired on December 21, 2022 through a dividend reinvestment plan.
F5 The option represents a right to purchase a total of 32,380 shares, and is exercisable in two installments of 10,793 shares each and one installment of 10,794 shares, beginning on 3/1/2024 which is the one-year anniversary of the option grant date.